Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole

NCT ID: NCT00485199

Last Updated: 2007-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

231 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-01-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To undertake a prospective randomized clinical study for treating retinal detachment due to myopic macular holes, utilizing pneumatic retinopexy versus pars plana vitrectomy with gas tamponade.To determine the efficiency of pneumatic retinopexy with C3F8 in the treatment of retinal detachment due to myopic macular hole.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retinal detachment caused by macular hole predominantly happened in high myopic eyes. This is a common type of retinal detachment in Asia and often seen in the old people aged around 50 \~ 60, mainly in female. Treatment of retinal detachment due to macular holes has changed over the years, and several methods have been described. Some surgeons have used transscleral diathermy or cryotherapy or laser photocoagulation and drainage subretinal fluid without sclera buckling, other surgeons have used radial silicone explants beneath the macular combined with cryo, diathermy or laser. This method entails the difficulty of placing sclera sutures far posterior, especially hazardous if there is a posterior staphyloma with very thin sclera. Besides the technically difficult, the extensive macular scarring caused by different coagulations limited the functional result to peripheral vision only. Because of this, it is not generally used in the initial treatment.

In 1982, Gonvers and Machemer4 proposed a new treatment technique that combined pars plana vitrectomy (PPV), partial air-fluid exchange, and face down positioning for 24 hours. Since then vitrectomy with gas tamponade become the most common procedure for retinal detachment with macular hole.

In 1984, Miyake performed a simple gas injection into the vitreous followed by a face-down position. The effective of this simplified method was then reported by many observers.But these studies may have insufficiency because of small sample, nonrandomized, no defined eligibility criteria for patients selection.

Intraocular gas tamponade with or without pars plana vitrectomy (PPV) has commonly been performed nowadays. We conducted a multicenter randomized controlled clinical trial to compare their anatomic results and visual outcomes of both surgical techniques, to estimate the efficiency of both surgical methods in the treatment of retinal detachment with myopic macular hole.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Detachment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pneumatic Retinopexy

Intervention Type PROCEDURE

Vitrectomy with Gas

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* retinal detachment due to myopic macular hole.
* The ability to give informed consent and to return for follow-up visit for 12 months

Exclusion Criteria

* retinal detachment with macular hole and peripheral hole/tear
* retinal detachment with severe proliferative vitreoretinopathy
* retinal detachment with choroidal detachment or rupture
* traction retinal detachment due to retinal vascular disease
* had vitrectomy in the past
* macular hole without retinal detachment
* foveal schiesis without retinal detachment
* secondary macular hole with retinal detachment
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaoxin Li, professor

Role: STUDY_CHAIR

Peking University

Jialiang Zhao, professor

Role: PRINCIPAL_INVESTIGATOR

Eye Institute of Peking Union Hospital, Peking Union Medical College

Wenji Wang, professor

Role: PRINCIPAL_INVESTIGATOR

Department of ophthalmology of Eye Ear Nose Throat Hospital, Fudan University, Shanghai

Shibo Tang, professor

Role: PRINCIPAL_INVESTIGATOR

Zhong Shan Ophthalmic Center, Sun Yat-sen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of ophthalmology of People Hospital, Peking University

Beijing, Beijing Municipality, China

Site Status

Department of ophthalmology of Beijing Hospital

Beijing, Beijing Municipality, China

Site Status

Department of ophthalmology of Beijing Tong Ren Hospital

Beijing, Beijing Municipality, China

Site Status

Department of ophthalmology of China PLA General Hospital

Beijing, Beijing Municipality, China

Site Status

Peking Eye Center of the third affiliated Hospital of Peking University

Beijing, Beijing Municipality, China

Site Status

Zhong Shan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status

Department of ophthalmology of The Second affiliated Xiang Ya Hospital, Central South University

Changsha, Hunan, China

Site Status

Department of ophthalmology of The First affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Site Status

Department of ophthalmology of The First affiliated Hospital of China Medical University

Shenyang, Liaoning, China

Site Status

Shandong Eye Institute

Qingdao, Shandong, China

Site Status

Department of ophthalmology of EENT Hospital, Fudan University

Shanghai, Shanghai Municipality, China

Site Status

Department of ophthalmology of The First affiliated People Hospital of Shang Hai Jiao Tong University

Shanghai, Shanghai Municipality, China

Site Status

Department of ophthalmology of West China Hospital, Sichuan University

Chengdu, Sichuan, China

Site Status

Tianjin Eye Hospital

Tianjin, Tianjin Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Schwartz SG, Flynn HW Jr, Wang X, Kuriyan AE, Abariga SA, Lee WH. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev. 2020 May 13;5(5):CD006126. doi: 10.1002/14651858.CD006126.pub4.

Reference Type DERIVED
PMID: 32408387 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RDMH2007-china

Identifier Type: -

Identifier Source: org_study_id